vivoVerse awarded SBIR Phase II grant from the NIEHS
vivoVerse (formerly operating as Newormics) is excited to announce it has been awarded a $1.83M Phase II SBIR grant from the National Institute of Environmental Health Sciences (NIEHS) for the continued development of the company’s in vivo imaging and screening technologies. vivoVerse’s core focus is to facilitate the use of C. elegans as a model organism for life-science research Read more about vivoVerse awarded SBIR Phase II grant from the NIEHS[…]